Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Procysbi, cysteamine bitartrate (Cysteamine bitartrate delayed-release capsules) (RP103)
Also known as: DR Cysteamine
print preview
bookmark
share with colleague
General Information
Company
Raptor Pharmaceutical Corp.
Description
Delayed-release formulation of a degradation product of the amino acid cysteine
Molecular Target
Not applicable
Mechanism of Action
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy